NOXXON Pharma AG We are a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers. Spiegelmers are the chemically synthesized, non-immunogenic alternative to antibodies. Located in Berlin, Germany, we are a well financed mature biotech company with a strong syndicate of international investors, approx. 60 employees and a highly experienced management team.